ab12251 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab12251 は 8 報の論文で使用されています。

  • Fantappiè L  et al. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. J Extracell Vesicles 3:N/A (2014). WB . PubMed: 25147647
  • Heggeset TM  et al. Combinatorial mutagenesis and selection of improved signal sequences and their application for high-level production of translocated heterologous proteins in Escherichia coli. Appl Environ Microbiol 79:559-68 (2013). WB . PubMed: 23144128
  • Bröms JE  et al. Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection. PLoS One 7:e50473 (2012). WB . PubMed: 23185631
  • Zhu W  et al. Comprehensive Identification of Protein Substrates of the Dot/Icm Type IV Transporter of Legionella pneumophila. PLoS One 6:e17638 (2011). WB . PubMed: 21408005
  • Miyata ST  et al. Vibrio cholerae requires the type VI secretion system virulence factor VasX to kill Dictyostelium discoideum. Infect Immun 79:2941-9 (2011). PubMed: 21555399
  • Wang Y  et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 7:e1002258 (2011). WB . PubMed: 21966270
  • Brinkworth AJ  et al. Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP. Mol Microbiol 82:131-44 (2011). WB . PubMed: 21883523
  • Waraho D & Delisa MP Versatile selection technology for intracellular protein-protein interactions mediated by a unique bacterial hitchhiker transport mechanism. Proc Natl Acad Sci U S A 106:3692-7 (2009). WB ; Escherichia coli . PubMed: 19234130

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"